UBS analyst AJ Rice raised the price target on Elevance (NYSE: ELV) to $605.00 (from $585.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Elevance (ELV) PT Raised to $575 at RBC CapitalApril 19, 2024 6:46 AM Elevance (ELV) PT Raised to $600 at Wells FargoApril 19, 2024 5:57 AM Elevance (ELV) PT Raised to $604 at JefferiesApril 19, 2024 5:46 AM Elevance (ELV) PT Raised to $621 at BarclaysApril 19, 2024 3:36 AM Elevance Health (ELV) April and May options active as share price up 4%April 18, 2024 3:27 PM Form 10-Q Elevance Health, Inc. For: Mar 31April 18, 2024 2:17 PM Elevance Health (ELV) hikes 2024 earnings outlook, shares climbApril 18, 2024 7:03 AM Form 8-K Elevance Health, Inc. For: Apr 18April 18, 2024 6:08 AM Elevance Health Inc. (ELV) Tops Q1 EPS by 16c, tops guidanceApril 18, 2024 6:01 AM Elevance Health Reports First Quarter 2024 ResultsApril 18, 2024 6:00 AM